Loading…

Integrated community-directed intervention for schistosomiasis and soil transmitted helminths in western Kenya – a pilot study

BACKGROUND: Schistosome and soil-transmitted helminth (STH) infections are recognized as major global public health problems, causing severe and subtle morbidity, including significant educational and nutritional effects in children. Although effective and safe drugs are available, ensuring access t...

Full description

Saved in:
Bibliographic Details
Published in:Parasites & vectors 2012-08, Vol.5 (1), p.182-182, Article 182
Main Authors: Mwinzi, Pauline NM, Montgomery, Susan P, Owaga, Chrispin O, Mwanje, Mariam, Muok, Erick M, Ayisi, John G, Laserson, Kayla F, Muchiri, Erick M, Secor, W Evan, Karanja, Diana MS
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b570t-48673e51edc0eabf514add952666d985b0bfd6fc1fee2aa3eabdd43c72d1d9203
cites cdi_FETCH-LOGICAL-b570t-48673e51edc0eabf514add952666d985b0bfd6fc1fee2aa3eabdd43c72d1d9203
container_end_page 182
container_issue 1
container_start_page 182
container_title Parasites & vectors
container_volume 5
creator Mwinzi, Pauline NM
Montgomery, Susan P
Owaga, Chrispin O
Mwanje, Mariam
Muok, Erick M
Ayisi, John G
Laserson, Kayla F
Muchiri, Erick M
Secor, W Evan
Karanja, Diana MS
description BACKGROUND: Schistosome and soil-transmitted helminth (STH) infections are recognized as major global public health problems, causing severe and subtle morbidity, including significant educational and nutritional effects in children. Although effective and safe drugs are available, ensuring access to these drugs by all those at risk of schistosomiasis and STHs is still a challenge. Community-directed intervention (CDI) has been used successfully for mass distribution of drugs for other diseases such as onchocerciasis and lymphatic filariasis. A national control programme is yet to be instituted in Kenya and evidence for cost-effective strategies for reaching most affected communities is needed. This study evaluated the effectiveness and feasibility of the CDI strategy in the control of schistosomiasis and STHs, in East Uyoma location, Rarieda district, a community of western Kenya that is highly endemic for both infections. RESULTS: Pre-treatment prevalence of S. mansoni averaged 17.4% (range 5-43%) in the entire location. Treatment coverage in different villages ranged from 54.19 to 96.6% by community drug distributor (CDD) records. Assessment from a household survey showed coverage of 52.3 -91.9% while the proportion of homesteads (home compounds) covered ranged from 54.9-98.5%. Six months after one round of drug distribution, the prevalence levels of S. mansoni, hookworm and Trichuris trichura infections were reduced by 33.2%, 69.4% and 42.6% respectively. CONCLUSIONS: This study shows that CDI is an accepted and effective strategy in the mass treatment of schistosomiasis and STH infections in resource constrained communities in Kenya and may be useful in similar communities elsewhere. A controlled trial comparing CDI and school based mass drug administration to demonstarte their relative advantages is ongoing.
doi_str_mv 10.1186/1756-3305-5-182
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_12b2477d6cb0417bacbac27483ef54d4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_12b2477d6cb0417bacbac27483ef54d4</doaj_id><sourcerecordid>2764529791</sourcerecordid><originalsourceid>FETCH-LOGICAL-b570t-48673e51edc0eabf514add952666d985b0bfd6fc1fee2aa3eabdd43c72d1d9203</originalsourceid><addsrcrecordid>eNp1ks2KFDEQxxtR3HX07E0DntvNd7ovgi5-DC540D2HdJKeydCdjEl6ZW77Dr6hT2LaXocdUAgkVP3rV5WqqqrnCL5GqOEXSDBeEwJZzWrU4AfV-dHy8N77rHqS0g5CDlvGH1dnGLdENC08r27XPttNVNkaoMM4Tt7lQ21ctHo2ueKNN9ZnFzzoQwRJb13KIYXRqeQSUN6AFNwAclQ-jS7PUVs7jCVym0o8-GFTYXjw2fqDAr9ufwIF9m4IGaQ8mcPT6lGvhmSf3d2r6vrD-2-Xn-qrLx_Xl2-v6o4JmGvacEEsQ9ZoaFXXM0SVMS3DnHPTNqyDXW94r1FvLVaKFI0xlGiBDTIthmRVrReuCWon99GNKh5kUE7-MYS4kSpmpwcrEe4wFcJw3UGKRKd0OVjQhtie0UJdVW8W1n7qxlJR6U9Uwwn01OPdVm7CjSSUCs5QAbxbAJ0L_wGcespo5DxNOU9TMllmXSCv7qqI4ftUuix3YYq-NFEiSGEr2hbPqS4WlY4hpWj7YxYE5bxD_-C-uP-7o_7v0hTBy0XQqyDVJrokr79iiBiEcPY35DeCx9Fj</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1040979921</pqid></control><display><type>article</type><title>Integrated community-directed intervention for schistosomiasis and soil transmitted helminths in western Kenya – a pilot study</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central(OpenAccess)</source><creator>Mwinzi, Pauline NM ; Montgomery, Susan P ; Owaga, Chrispin O ; Mwanje, Mariam ; Muok, Erick M ; Ayisi, John G ; Laserson, Kayla F ; Muchiri, Erick M ; Secor, W Evan ; Karanja, Diana MS</creator><creatorcontrib>Mwinzi, Pauline NM ; Montgomery, Susan P ; Owaga, Chrispin O ; Mwanje, Mariam ; Muok, Erick M ; Ayisi, John G ; Laserson, Kayla F ; Muchiri, Erick M ; Secor, W Evan ; Karanja, Diana MS</creatorcontrib><description>BACKGROUND: Schistosome and soil-transmitted helminth (STH) infections are recognized as major global public health problems, causing severe and subtle morbidity, including significant educational and nutritional effects in children. Although effective and safe drugs are available, ensuring access to these drugs by all those at risk of schistosomiasis and STHs is still a challenge. Community-directed intervention (CDI) has been used successfully for mass distribution of drugs for other diseases such as onchocerciasis and lymphatic filariasis. A national control programme is yet to be instituted in Kenya and evidence for cost-effective strategies for reaching most affected communities is needed. This study evaluated the effectiveness and feasibility of the CDI strategy in the control of schistosomiasis and STHs, in East Uyoma location, Rarieda district, a community of western Kenya that is highly endemic for both infections. RESULTS: Pre-treatment prevalence of S. mansoni averaged 17.4% (range 5-43%) in the entire location. Treatment coverage in different villages ranged from 54.19 to 96.6% by community drug distributor (CDD) records. Assessment from a household survey showed coverage of 52.3 -91.9% while the proportion of homesteads (home compounds) covered ranged from 54.9-98.5%. Six months after one round of drug distribution, the prevalence levels of S. mansoni, hookworm and Trichuris trichura infections were reduced by 33.2%, 69.4% and 42.6% respectively. CONCLUSIONS: This study shows that CDI is an accepted and effective strategy in the mass treatment of schistosomiasis and STH infections in resource constrained communities in Kenya and may be useful in similar communities elsewhere. A controlled trial comparing CDI and school based mass drug administration to demonstarte their relative advantages is ongoing.</description><identifier>ISSN: 1756-3305</identifier><identifier>EISSN: 1756-3305</identifier><identifier>DOI: 10.1186/1756-3305-5-182</identifier><identifier>PMID: 22937890</identifier><language>eng</language><publisher>England: Springer-Verlag</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Albendazole - adverse effects ; Albendazole - economics ; Albendazole - therapeutic use ; Animals ; Anthelmintics - adverse effects ; Anthelmintics - economics ; Anthelmintics - therapeutic use ; Child ; Child, Preschool ; children ; community programs ; cost effectiveness ; Cost-Benefit Analysis ; Delivery of Health Care - methods ; disease control ; drugs ; Feasibility Studies ; Female ; Health care ; Helminthiasis - drug therapy ; Helminthiasis - epidemiology ; Helminthiasis - parasitology ; Hookworm Infections - drug therapy ; Hookworm Infections - epidemiology ; Hookworm Infections - parasitology ; hookworms ; Humans ; Kenya - epidemiology ; Male ; Medical research ; Middle Aged ; morbidity ; onchocerciasis ; Pilot Projects ; Praziquantel - adverse effects ; Praziquantel - economics ; Praziquantel - therapeutic use ; pretreatment ; Prevalence ; Public health ; risk ; schistosomiasis ; Schistosomiasis - drug therapy ; Schistosomiasis - epidemiology ; Schistosomiasis - parasitology ; Socioeconomic Factors ; soil ; Soil - parasitology ; Studies ; surveys ; Trichuriasis - drug therapy ; Trichuriasis - epidemiology ; Trichuriasis - parasitology ; Trichuris ; Tropical diseases ; villages</subject><ispartof>Parasites &amp; vectors, 2012-08, Vol.5 (1), p.182-182, Article 182</ispartof><rights>2012 Mwinzi et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright ©2012 Mwinzi et al.; licensee BioMed Central Ltd. 2012 Mwinzi et al.; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b570t-48673e51edc0eabf514add952666d985b0bfd6fc1fee2aa3eabdd43c72d1d9203</citedby><cites>FETCH-LOGICAL-b570t-48673e51edc0eabf514add952666d985b0bfd6fc1fee2aa3eabdd43c72d1d9203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447651/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1040979921?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22937890$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mwinzi, Pauline NM</creatorcontrib><creatorcontrib>Montgomery, Susan P</creatorcontrib><creatorcontrib>Owaga, Chrispin O</creatorcontrib><creatorcontrib>Mwanje, Mariam</creatorcontrib><creatorcontrib>Muok, Erick M</creatorcontrib><creatorcontrib>Ayisi, John G</creatorcontrib><creatorcontrib>Laserson, Kayla F</creatorcontrib><creatorcontrib>Muchiri, Erick M</creatorcontrib><creatorcontrib>Secor, W Evan</creatorcontrib><creatorcontrib>Karanja, Diana MS</creatorcontrib><title>Integrated community-directed intervention for schistosomiasis and soil transmitted helminths in western Kenya – a pilot study</title><title>Parasites &amp; vectors</title><addtitle>Parasit Vectors</addtitle><description>BACKGROUND: Schistosome and soil-transmitted helminth (STH) infections are recognized as major global public health problems, causing severe and subtle morbidity, including significant educational and nutritional effects in children. Although effective and safe drugs are available, ensuring access to these drugs by all those at risk of schistosomiasis and STHs is still a challenge. Community-directed intervention (CDI) has been used successfully for mass distribution of drugs for other diseases such as onchocerciasis and lymphatic filariasis. A national control programme is yet to be instituted in Kenya and evidence for cost-effective strategies for reaching most affected communities is needed. This study evaluated the effectiveness and feasibility of the CDI strategy in the control of schistosomiasis and STHs, in East Uyoma location, Rarieda district, a community of western Kenya that is highly endemic for both infections. RESULTS: Pre-treatment prevalence of S. mansoni averaged 17.4% (range 5-43%) in the entire location. Treatment coverage in different villages ranged from 54.19 to 96.6% by community drug distributor (CDD) records. Assessment from a household survey showed coverage of 52.3 -91.9% while the proportion of homesteads (home compounds) covered ranged from 54.9-98.5%. Six months after one round of drug distribution, the prevalence levels of S. mansoni, hookworm and Trichuris trichura infections were reduced by 33.2%, 69.4% and 42.6% respectively. CONCLUSIONS: This study shows that CDI is an accepted and effective strategy in the mass treatment of schistosomiasis and STH infections in resource constrained communities in Kenya and may be useful in similar communities elsewhere. A controlled trial comparing CDI and school based mass drug administration to demonstarte their relative advantages is ongoing.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Albendazole - adverse effects</subject><subject>Albendazole - economics</subject><subject>Albendazole - therapeutic use</subject><subject>Animals</subject><subject>Anthelmintics - adverse effects</subject><subject>Anthelmintics - economics</subject><subject>Anthelmintics - therapeutic use</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>children</subject><subject>community programs</subject><subject>cost effectiveness</subject><subject>Cost-Benefit Analysis</subject><subject>Delivery of Health Care - methods</subject><subject>disease control</subject><subject>drugs</subject><subject>Feasibility Studies</subject><subject>Female</subject><subject>Health care</subject><subject>Helminthiasis - drug therapy</subject><subject>Helminthiasis - epidemiology</subject><subject>Helminthiasis - parasitology</subject><subject>Hookworm Infections - drug therapy</subject><subject>Hookworm Infections - epidemiology</subject><subject>Hookworm Infections - parasitology</subject><subject>hookworms</subject><subject>Humans</subject><subject>Kenya - epidemiology</subject><subject>Male</subject><subject>Medical research</subject><subject>Middle Aged</subject><subject>morbidity</subject><subject>onchocerciasis</subject><subject>Pilot Projects</subject><subject>Praziquantel - adverse effects</subject><subject>Praziquantel - economics</subject><subject>Praziquantel - therapeutic use</subject><subject>pretreatment</subject><subject>Prevalence</subject><subject>Public health</subject><subject>risk</subject><subject>schistosomiasis</subject><subject>Schistosomiasis - drug therapy</subject><subject>Schistosomiasis - epidemiology</subject><subject>Schistosomiasis - parasitology</subject><subject>Socioeconomic Factors</subject><subject>soil</subject><subject>Soil - parasitology</subject><subject>Studies</subject><subject>surveys</subject><subject>Trichuriasis - drug therapy</subject><subject>Trichuriasis - epidemiology</subject><subject>Trichuriasis - parasitology</subject><subject>Trichuris</subject><subject>Tropical diseases</subject><subject>villages</subject><issn>1756-3305</issn><issn>1756-3305</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1ks2KFDEQxxtR3HX07E0DntvNd7ovgi5-DC540D2HdJKeydCdjEl6ZW77Dr6hT2LaXocdUAgkVP3rV5WqqqrnCL5GqOEXSDBeEwJZzWrU4AfV-dHy8N77rHqS0g5CDlvGH1dnGLdENC08r27XPttNVNkaoMM4Tt7lQ21ctHo2ueKNN9ZnFzzoQwRJb13KIYXRqeQSUN6AFNwAclQ-jS7PUVs7jCVym0o8-GFTYXjw2fqDAr9ufwIF9m4IGaQ8mcPT6lGvhmSf3d2r6vrD-2-Xn-qrLx_Xl2-v6o4JmGvacEEsQ9ZoaFXXM0SVMS3DnHPTNqyDXW94r1FvLVaKFI0xlGiBDTIthmRVrReuCWon99GNKh5kUE7-MYS4kSpmpwcrEe4wFcJw3UGKRKd0OVjQhtie0UJdVW8W1n7qxlJR6U9Uwwn01OPdVm7CjSSUCs5QAbxbAJ0L_wGcespo5DxNOU9TMllmXSCv7qqI4ftUuix3YYq-NFEiSGEr2hbPqS4WlY4hpWj7YxYE5bxD_-C-uP-7o_7v0hTBy0XQqyDVJrokr79iiBiEcPY35DeCx9Fj</recordid><startdate>20120831</startdate><enddate>20120831</enddate><creator>Mwinzi, Pauline NM</creator><creator>Montgomery, Susan P</creator><creator>Owaga, Chrispin O</creator><creator>Mwanje, Mariam</creator><creator>Muok, Erick M</creator><creator>Ayisi, John G</creator><creator>Laserson, Kayla F</creator><creator>Muchiri, Erick M</creator><creator>Secor, W Evan</creator><creator>Karanja, Diana MS</creator><general>Springer-Verlag</general><general>BioMed Central</general><general>BioMed Central Ltd</general><general>BMC</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7SN</scope><scope>7SS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>F1W</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H95</scope><scope>K9.</scope><scope>L.G</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20120831</creationdate><title>Integrated community-directed intervention for schistosomiasis and soil transmitted helminths in western Kenya – a pilot study</title><author>Mwinzi, Pauline NM ; Montgomery, Susan P ; Owaga, Chrispin O ; Mwanje, Mariam ; Muok, Erick M ; Ayisi, John G ; Laserson, Kayla F ; Muchiri, Erick M ; Secor, W Evan ; Karanja, Diana MS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b570t-48673e51edc0eabf514add952666d985b0bfd6fc1fee2aa3eabdd43c72d1d9203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Albendazole - adverse effects</topic><topic>Albendazole - economics</topic><topic>Albendazole - therapeutic use</topic><topic>Animals</topic><topic>Anthelmintics - adverse effects</topic><topic>Anthelmintics - economics</topic><topic>Anthelmintics - therapeutic use</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>children</topic><topic>community programs</topic><topic>cost effectiveness</topic><topic>Cost-Benefit Analysis</topic><topic>Delivery of Health Care - methods</topic><topic>disease control</topic><topic>drugs</topic><topic>Feasibility Studies</topic><topic>Female</topic><topic>Health care</topic><topic>Helminthiasis - drug therapy</topic><topic>Helminthiasis - epidemiology</topic><topic>Helminthiasis - parasitology</topic><topic>Hookworm Infections - drug therapy</topic><topic>Hookworm Infections - epidemiology</topic><topic>Hookworm Infections - parasitology</topic><topic>hookworms</topic><topic>Humans</topic><topic>Kenya - epidemiology</topic><topic>Male</topic><topic>Medical research</topic><topic>Middle Aged</topic><topic>morbidity</topic><topic>onchocerciasis</topic><topic>Pilot Projects</topic><topic>Praziquantel - adverse effects</topic><topic>Praziquantel - economics</topic><topic>Praziquantel - therapeutic use</topic><topic>pretreatment</topic><topic>Prevalence</topic><topic>Public health</topic><topic>risk</topic><topic>schistosomiasis</topic><topic>Schistosomiasis - drug therapy</topic><topic>Schistosomiasis - epidemiology</topic><topic>Schistosomiasis - parasitology</topic><topic>Socioeconomic Factors</topic><topic>soil</topic><topic>Soil - parasitology</topic><topic>Studies</topic><topic>surveys</topic><topic>Trichuriasis - drug therapy</topic><topic>Trichuriasis - epidemiology</topic><topic>Trichuriasis - parasitology</topic><topic>Trichuris</topic><topic>Tropical diseases</topic><topic>villages</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mwinzi, Pauline NM</creatorcontrib><creatorcontrib>Montgomery, Susan P</creatorcontrib><creatorcontrib>Owaga, Chrispin O</creatorcontrib><creatorcontrib>Mwanje, Mariam</creatorcontrib><creatorcontrib>Muok, Erick M</creatorcontrib><creatorcontrib>Ayisi, John G</creatorcontrib><creatorcontrib>Laserson, Kayla F</creatorcontrib><creatorcontrib>Muchiri, Erick M</creatorcontrib><creatorcontrib>Secor, W Evan</creatorcontrib><creatorcontrib>Karanja, Diana MS</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 1: Biological Sciences &amp; Living Resources</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Parasites &amp; vectors</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mwinzi, Pauline NM</au><au>Montgomery, Susan P</au><au>Owaga, Chrispin O</au><au>Mwanje, Mariam</au><au>Muok, Erick M</au><au>Ayisi, John G</au><au>Laserson, Kayla F</au><au>Muchiri, Erick M</au><au>Secor, W Evan</au><au>Karanja, Diana MS</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Integrated community-directed intervention for schistosomiasis and soil transmitted helminths in western Kenya – a pilot study</atitle><jtitle>Parasites &amp; vectors</jtitle><addtitle>Parasit Vectors</addtitle><date>2012-08-31</date><risdate>2012</risdate><volume>5</volume><issue>1</issue><spage>182</spage><epage>182</epage><pages>182-182</pages><artnum>182</artnum><issn>1756-3305</issn><eissn>1756-3305</eissn><abstract>BACKGROUND: Schistosome and soil-transmitted helminth (STH) infections are recognized as major global public health problems, causing severe and subtle morbidity, including significant educational and nutritional effects in children. Although effective and safe drugs are available, ensuring access to these drugs by all those at risk of schistosomiasis and STHs is still a challenge. Community-directed intervention (CDI) has been used successfully for mass distribution of drugs for other diseases such as onchocerciasis and lymphatic filariasis. A national control programme is yet to be instituted in Kenya and evidence for cost-effective strategies for reaching most affected communities is needed. This study evaluated the effectiveness and feasibility of the CDI strategy in the control of schistosomiasis and STHs, in East Uyoma location, Rarieda district, a community of western Kenya that is highly endemic for both infections. RESULTS: Pre-treatment prevalence of S. mansoni averaged 17.4% (range 5-43%) in the entire location. Treatment coverage in different villages ranged from 54.19 to 96.6% by community drug distributor (CDD) records. Assessment from a household survey showed coverage of 52.3 -91.9% while the proportion of homesteads (home compounds) covered ranged from 54.9-98.5%. Six months after one round of drug distribution, the prevalence levels of S. mansoni, hookworm and Trichuris trichura infections were reduced by 33.2%, 69.4% and 42.6% respectively. CONCLUSIONS: This study shows that CDI is an accepted and effective strategy in the mass treatment of schistosomiasis and STH infections in resource constrained communities in Kenya and may be useful in similar communities elsewhere. A controlled trial comparing CDI and school based mass drug administration to demonstarte their relative advantages is ongoing.</abstract><cop>England</cop><pub>Springer-Verlag</pub><pmid>22937890</pmid><doi>10.1186/1756-3305-5-182</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1756-3305
ispartof Parasites & vectors, 2012-08, Vol.5 (1), p.182-182, Article 182
issn 1756-3305
1756-3305
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_12b2477d6cb0417bacbac27483ef54d4
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central(OpenAccess)
subjects Adolescent
Adult
Aged
Aged, 80 and over
Albendazole - adverse effects
Albendazole - economics
Albendazole - therapeutic use
Animals
Anthelmintics - adverse effects
Anthelmintics - economics
Anthelmintics - therapeutic use
Child
Child, Preschool
children
community programs
cost effectiveness
Cost-Benefit Analysis
Delivery of Health Care - methods
disease control
drugs
Feasibility Studies
Female
Health care
Helminthiasis - drug therapy
Helminthiasis - epidemiology
Helminthiasis - parasitology
Hookworm Infections - drug therapy
Hookworm Infections - epidemiology
Hookworm Infections - parasitology
hookworms
Humans
Kenya - epidemiology
Male
Medical research
Middle Aged
morbidity
onchocerciasis
Pilot Projects
Praziquantel - adverse effects
Praziquantel - economics
Praziquantel - therapeutic use
pretreatment
Prevalence
Public health
risk
schistosomiasis
Schistosomiasis - drug therapy
Schistosomiasis - epidemiology
Schistosomiasis - parasitology
Socioeconomic Factors
soil
Soil - parasitology
Studies
surveys
Trichuriasis - drug therapy
Trichuriasis - epidemiology
Trichuriasis - parasitology
Trichuris
Tropical diseases
villages
title Integrated community-directed intervention for schistosomiasis and soil transmitted helminths in western Kenya – a pilot study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T14%3A20%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Integrated%20community-directed%20intervention%20for%20schistosomiasis%20and%20soil%20transmitted%20helminths%20in%20western%20Kenya%20%E2%80%93%20a%20pilot%20study&rft.jtitle=Parasites%20&%20vectors&rft.au=Mwinzi,%20Pauline%20NM&rft.date=2012-08-31&rft.volume=5&rft.issue=1&rft.spage=182&rft.epage=182&rft.pages=182-182&rft.artnum=182&rft.issn=1756-3305&rft.eissn=1756-3305&rft_id=info:doi/10.1186/1756-3305-5-182&rft_dat=%3Cproquest_doaj_%3E2764529791%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b570t-48673e51edc0eabf514add952666d985b0bfd6fc1fee2aa3eabdd43c72d1d9203%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1040979921&rft_id=info:pmid/22937890&rfr_iscdi=true